Predicting "unresectable" ovarian cancer: Taking aim at a moving target

被引：16

作者：

Bristow, RE

机构：

[1] Johns Hopkins Med Inst, Kelly Gynecol Oncol Serv, Dept Gynecol & Obstet, Baltimore, MD 21287 USA

[2] Johns Hopkins Med Inst, Kelly Gynecol Oncol Serv, Dept Oncol, Baltimore, MD 21287 USA

来源：

GYNECOLOGIC ONCOLOGY | 2006年 / 100卷 / 03期

关键词：

D O I：

10.1016/j.ygyno.2006.01.005

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：449 / 450

页数：2

共 19 条

[1] Aggressive surgical effort and improved survival in advanced-stage ovarian cancer [J].

Aletti, GD ;

Dowdy, SC ;

Gostout, BS ;

Jones, MB ;

Stanhope, CR ;

Wilson, TO ;

Podratz, KC ;

Cliby, WA .

OBSTETRICS AND GYNECOLOGY, 2006, 107 (01) :77-85

[2] Ovarian cancer surgical resectability: Relative impact of disease, patient status, and surgeon [J].

Aletti, GD ;

Gostout, BS ;

Podratz, KC ;

Cliby, WA .

GYNECOLOGIC ONCOLOGY, 2006, 100 (01) :33-37

[3] Diagnostic open laparoscopy in the management of advanced ovarian cancer [J].

Angioli, R ;

Palaia, I ;

Zullo, MA ;

Muzii, L ;

Manci, N ;

Calcagno, M ;

Panici, PB .

GYNECOLOGIC ONCOLOGY, 2006, 100 (03) :455-461

[4]

Bristow RE, 2000, CANCER, V89, P1532, DOI 10.1002/1097-0142(20001001)89:7<1532::AID-CNCR17>3.0.CO

[5]

2-A

[6] Ovarian cancer surgery in Maryland: volume-based access to care [J].

Bristow, RE ;

Zahurak, ML ;

del Carmen, MG ;

Gordon, TA ;

Fox, HE ;

Trimble, EL ;

Montz, FJ .

GYNECOLOGIC ONCOLOGY, 2004, 93 (02) :353-360

[7] A population-based study of patterns of care for ovarian cancer: Who is seen by a gynecologic oncologist and who is not? [J].

Carney, ME ;

Lancaster, JM ;

Ford, C ;

Tsodikov, A ;

Wiggins, CL .

GYNECOLOGIC ONCOLOGY, 2002, 84 (01) :36-42

[8] Improved optimal cytoreduction rates for stages IIIC and IV epithelial ovarian, fallopian tube, and primary peritoneal cancer: a change in surgical approach [J].

Chi, DS ;

Franklin, CC ;

Levine, DA ;

Akselrod, F ;

Sabbatini, P ;

Jarnagin, WR ;

DeMatteo, R ;

Poynor, EA ;

Abu-Rustum, NR ;

Barakat, RR .

GYNECOLOGIC ONCOLOGY, 2004, 94 (03) :650-654

[9] The ability of preoperative serum CA-125 to predict optimal primary tumor cytoreduction in stage III epithelial ovarian carcinoma [J].

Chi, DS ;

Venkatraman, ES ;

Masson, V ;

Hoskins, WJ .

GYNECOLOGIC ONCOLOGY, 2000, 77 (02) :227-231

[10] Identification of prognostic factors in advanced epithelial ovarian carcinoma [J].

Chi, DS ;

Liao, JB ;

Leon, LF ;

Venkatraman, ES ;

Hensley, ML ;

Bhaskaran, D ;

Hoskins, WJ .

GYNECOLOGIC ONCOLOGY, 2001, 82 (03) :532-537

← 1 2 →